MEDSURGE HYDROMORPHONE 2 mg/1 mL hydromorphone hydrochloride 2 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge hydromorphone 2 mg/1 ml hydromorphone hydrochloride 2 mg/1 ml injection ampoule

medsurge pharma pty ltd - hydromorphone hydrochloride, quantity: 2 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; citric acid; sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEDSURGE HYDROMORPHONE XHP 50 mg/1 mL hydromorphone hydrochloride 50 mg/1 mL concentrated injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge hydromorphone xhp 50 mg/1 ml hydromorphone hydrochloride 50 mg/1 ml concentrated injection ampoule

medsurge pharma pty ltd - hydromorphone hydrochloride, quantity: 50 mg - injection, concentrated - excipient ingredients: citric acid; sodium chloride; sodium citrate dihydrate; water for injections; hydrochloric acid; sodium hydroxide - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEDSURGE HYDROMORPHONE HP 20 mg/1 mL hydromorphone hydrochloride 20 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge hydromorphone hp 20 mg/1 ml hydromorphone hydrochloride 20 mg/1 ml injection ampoule

medsurge pharma pty ltd - hydromorphone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEDSURGE HYDROMORPHONE HP 100 mg/10 mL hydromorphone hydrochloride 100 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge hydromorphone hp 100 mg/10 ml hydromorphone hydrochloride 100 mg/10 ml injection ampoule

medsurge pharma pty ltd - hydromorphone hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide; citric acid; sodium citrate dihydrate - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Hydromorphone-HCl Krugmann 1.3 mg capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone-hcl krugmann 1.3 mg capsules, hard

mundipharma pharmaceuticals limited - hydromorphone hydrochloride - capsule, hard - 1.3 milligram(s) - hydromorphone

Hydromorphone-HCl Krugmann 2.6 mg capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone-hcl krugmann 2.6 mg capsules, hard

mundipharma pharmaceuticals limited - hydromorphone hydrochloride - capsule, hard - 2.6 milligram(s) - hydromorphone

EXALGO- hydromorphone hydrochloride tablet, extended release United States - English - NLM (National Library of Medicine)

exalgo- hydromorphone hydrochloride tablet, extended release

physicians total care, inc. - hydromorphone hydrochloride (unii: l960up2krw) (hydromorphone - unii:q812464r06) - hydromorphone hydrochloride 8 mg - exalgo is indicated for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. patients considered opioid tolerant are those who are taking at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl/hour, 30 mg oral oxycodone/day, 8 mg oral hydromorphone/day, 25 mg oral oxymorphone/day or an equianalgesic dose of another opioid, for a week or longer. limitations of use exalgo is not for use: - as an as-needed (prn) analgesic - for pain that is mild or not expected to persist for an extended period of time - for acute pain - for postoperative pain. exalgo is contraindicated in: - opioid non-tolerant patients. fatal respiratory depression could occur in patients who are not opioid tolerant. - patients with significant respiratory depression - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment - patients with known or suspected paralytic

DILAUDID hydromorphone hydrochloride 1mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dilaudid hydromorphone hydrochloride 1mg/ml oral liquid bottle

mundipharma pty ltd - hydromorphone hydrochloride -

DILAUDID hydromorphone hydrochloride 8mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dilaudid hydromorphone hydrochloride 8mg tablet bottle

mundipharma pty ltd - hydromorphone hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose - dilaudid is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

DILAUDID hydromorphone hydrochloride 4mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dilaudid hydromorphone hydrochloride 4mg tablet bottle

mundipharma pty ltd - hydromorphone hydrochloride, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose; quinoline yellow aluminium lake; magnesium stearate - dilaudid is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.